Marimastat
- Generic Name
- Marimastat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H29N3O5
- CAS Number
- 154039-60-8
- Unique Ingredient Identifier
- D5EQV23TDS
- Background
Used in the treatment of cancer, Marmiastat is an angiogenesis and metastasis inhibitor. As an angiogenesis inhibitor it limits the growth and production of blood vessels. As an antimetatstatic agent it prevents malignant cells from breaching the basement membranes.
- Indication
For the treatment of various cancers
- Associated Conditions
- -
- Associated Therapies
- -
CWR expands clinical trials to tackle high disease burden in Nigeria, others
Cures Within Reach (CWR) extends partnership with Open Philanthropy to fund 16 clinical trials in low and lower-middle income countries over two years, focusing on affordable treatments using existing medicines, nutraceuticals, and indigenous remedies. The initiative aims to benefit patients in these regions and strengthen local healthcare infrastructure. CWR has already funded successful trials, including a Phase 1 trial in Kenya for snakebite treatment, leading to a $5.4 million grant for a Phase 2B trial in Brazil and Ghana. Future trials will prioritize community engagement and local partnerships.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath